ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,838Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 142

$529K Total Retail Price of All Prescriptions

Rank: 8 out of 142

379 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

12% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

5% of this provider’s 5,933 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 421 329 1 3
LEVOTHYROXINE SODIUM 364 261 2 26
LOVASTATIN 307 279 3 44
OXYCODONE HCL 206 73 S2 4 63
METFORMIN HCL 203 146 5 32
SIMVASTATIN 188 159 6 14
FUROSEMIDE 180 127 7 1
HYDROCODONE-ACETAMINOPHEN 179 113 S3 8 36
OXYCODONE-ACETAMINOPHEN 177 71 S2 9 58
DICLOFENAC SODIUM 159 119 10 75
GABAPENTIN 158 112 11 31
OMEPRAZOLE 153 116 12 25
ATENOLOL 148 129 13 27
AMLODIPINE BESYLATE 141 119 14 2
MORPHINE SULFATE ER 135 0 S2 15 81
ZOLPIDEM TARTRATE 130 101 16 61
GLYBURIDE 128 108 R 17 82
ALLOPURINOL 127 80 18 5
METOPROLOL TARTRATE 118 74 19 7
MINOXIDIL 114 78 20 70
GEMFIBROZIL 99 51 21 47
PROAIR HFA 90 51 22 79
HYDROCHLOROTHIAZIDE 90 83 22 16
TRIAMTERENE-HCTZ 90 64 22 84
FLUOXETINE HCL 84 51 25 85
RANITIDINE HCL 81 65 26 53
WARFARIN SODIUM 78 61 27 71
CARISOPRODOL 75 0 R 28 89
OXYCONTIN 74 16 S2 29 90
LANTUS 70 46 30 49
FLUTICASONE PROPIONATE 66 36 31 95
ALENDRONATE SODIUM 65 62 32 78
AMITRIPTYLINE HCL 65 43 R 32 67
VYTORIN 65 54 32 96
PREDNISONE 62 46 35 23
METOCLOPRAMIDE HCL 60 19 36 100
GLIPIZIDE 60 60 36 38
POTASSIUM CHLORIDE 59 47 38 18
PRAVASTATIN SODIUM 59 52 38 37
MORPHINE SULFATE 57 12 S2 40 107
INSULIN SYRINGE 55 33 41 73
TRAMADOL HCL 55 31 41 43
ATORVASTATIN CALCIUM 55 32 41 59
ESTRADIOL 53 40 R 44 110
HYDROMORPHONE HCL 51 17 S2 45 114
ACETAMINOPHEN-CODEINE 50 46 S3 46 62
PROPRANOLOL HCL 50 34 46 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.